זימקסיד

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

GATIFLOXACIN 0.5 %W/V

Dostupno od:

ALLERGAN ISRAEL LTD

ATC koda:

S01AX21

Farmaceutski oblik:

OPHTHALMIC SOLUTION

Administracija rute:

OCULAR

Proizveden od:

ALLERGAN INC., USA

Terapijska grupa:

GATIFLOXACIN

Terapijske indikacije:

Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.

Datum autorizacije:

2012-11-01